ArticleCancer management and research2022

Predictive Factors Correlated with the Development of Immune-Related Adverse Events in Patients with Non-Small Cell Lung Cancer Treated with Immune Checkpoint Inhibitors.

Kei Sonehara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.